selected scholarly activity
-
academic article
- Genetic Risk Factors Are Not Associated with Wet Age-Related Macular Degeneration Treatment Response to Ranibizumab.. Ophthalmologica. 239:240. 2018
- Discrepancies in physician-patient agreement in reporting ocular history.. Canadian Journal of Ophthalmology. 51:378-381. 2016
- Ozurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study).. Canadian Journal of Ophthalmology. 51:302-305. 2016
- Predictors of functional vision changes after cataract surgery: the PROVISION study.. Canadian Journal of Ophthalmology. 51:265-270. 2016
- Ophthalmic referrals from emergency wards-a study of cases referred for urgent eye care (The R.E.S.C.U.E Study).. Canadian Journal of Ophthalmology. 51:174-179. 2016
- Waiting room educational media effect on preinjection anxiety for initial intravitreal injections.. Canadian Journal of Ophthalmology. 51:71-75. 2016
- Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response.. Ophthalmologica. 236:88-94. 2016
- Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus.. Ophthalmologica. 234:6-25. 2015
- Incidence of retinopathy of prematurity and risk factors among premature infants at a neonatal intensive care unit in Canada.. Journal of Pediatric Ophthalmology and Strabismus Journal of Pediatric Ophthalmology. 50:27-32. 2013
- Re-operation of idiopathic full-thickness macular holes after initial surgery with internal limiting membrane peel.. British Journal of Ophthalmology. 95:1564-1567. 2011
- Ranibizumab and the eye.. CMAJ. 183:822. 2011
- Age-related macular degeneration.. CMAJ. 182:1759. 2010
- ... Diabetic retinopathy. Canadian Medical Association Journal. 182:1646-1646. 2010